Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021
Vasomotor symptoms, such as hot flushes and nocturnal sweats, are experienced by 60 –80 % of all European women at some point during the menopausal transition [1]. The most effective treatment to reduce vasomotor symptoms is menopausal hormone therapy (MHT) [2], also referred to as hormone replacement therapy (HRT).
Source: Maturitas - Category: Primary Care Authors: Micaela Sundell, Jan Brynhildsen, Anna-Clara Spetz Holm, Mats Fredrikson, Mikael Hoffmann Tags: Original article Source Type: research
More News: Hormonal Therapy | Hormone Replacement Therapy | Hormones | Men | Menopause | Primary Care | Sweden Health | Women